Cargando…
Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum
Threats of bioterrorism have renewed efforts to better understand poxvirus pathogenesis and to develop a safer vaccine against smallpox. Individuals with atopic dermatitis are excluded from smallpox vaccination because of their propensity to develop eczema vaccinatum, a disseminated vaccinia virus (...
Autores principales: | Kawakami, Yuko, Tomimori, Yoshiaki, Yumoto, Kenji, Hasegawa, Shunji, Ando, Tomoaki, Tagaya, Yutaka, Crotty, Shane, Kawakami, Toshiaki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715052/ https://www.ncbi.nlm.nih.gov/pubmed/19468065 http://dx.doi.org/10.1084/jem.20082835 |
Ejemplares similares
-
Vaccinia immune globulin ameliorates eczema vaccinatum in a murine model of atopic dermatitis
por: Oyoshi, Michiko K., et al.
Publicado: (2011) -
Development of Eczema Vaccinatum in Atopic Mouse Models and Efficacy of MVA Vaccination against Lethal Poxviral Infection
por: Knitlova, Jarmila, et al.
Publicado: (2014) -
Hypothetical Atopic Dermatitis-Myeloproliferative Neoplasm Syndrome
por: Kawakami, Toshiaki, et al.
Publicado: (2015) -
Short Stat5-Interacting Peptide Derived from Phospholipase C-β3 Inhibits Hematopoietic Cell Proliferation and Myeloid Differentiation
por: Yasudo, Hiroki, et al.
Publicado: (2011) -
The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
por: Sumimoto, Hidetoshi, et al.
Publicado: (2006)